Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. - Wikidata - awgldk - TriplyDB

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.

http://www.wikidata.org/entity/Q35152116

about

Antifibrotic therapies to control cardiac fibrosis A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice Angiotensin-converting enzyme 2: the first decade.p47(phox) contributes to albuminuria and kidney fibrosis in mice.ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy Genetic Deletion of ACE2 Induces Vascular Dysfunction in C57BL/6 Mice: Role of Nitric Oxide Imbalance and Oxidative Stress Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2 ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis Angiotensin II and oxidative stress in the failing heart Angiotensin-converting enzyme 2 as a therapeutic target for heart failure Role of ACE2 in diastolic and systolic heart failure.The renin-angiotensin system, bone marrow and progenitor cells.The ACE2 gene: its potential as a functional candidate for cardiovascular disease.Novel aspects of ROS signalling in heart failure.Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.ACE2/Ang-(1-7) signaling and vascular remodeling.Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.Loss of TIMP3 selectively exacerbates diabetic nephropathy.Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease.The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling.Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease.Determinants of ventricular arrhythmias in human explanted hearts with dilated cardiomyopathy.Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells.

P2860

Q26745841-EA16A0BF-0AF3-4F42-8200-ADB589A88FBB Q28072451-CB74895B-23A0-4534-B35C-5A4CEEF8875E Q28541744-48212326-7509-4CD9-9183-353D4FD24022 Q34158064-C20006F2-DD56-4929-927B-0CBDF521E2DE Q34302600-00F0559A-D02F-4A00-ACA5-EB8F5579C00B Q34651371-878F9C25-F6A3-44CB-AA2C-D196A572AEE4 Q34866649-61F536EA-9754-4581-A104-5EDF404F112B Q34997831-C858FBBC-AE9A-4370-AAA2-C1D0E80FE573 Q35550937-9C36FA4C-C1E0-4103-9F02-B6D4EF33594C Q35587361-478F4D39-C111-490D-B2FB-6CA3C8206A41 Q35760437-B4568C0A-9E0E-44FE-9B01-455CD7712047 Q35986974-0CDE957C-2BCB-41BC-9FBF-522A54151033 Q36087047-7537C0B3-C4C2-4138-94DA-5895A2BF4C03 Q36337135-A40AA136-A4A2-4B67-9965-493BBDB717EC Q36581739-8F366D65-9EC1-4D33-82A8-71C3FD7042FF Q36829137-CC2C8732-C283-426A-BE23-7ADB91545BA2 Q37081415-3AF364C3-18AC-4924-B037-8E65BF2D1BFD Q37101896-655336DD-6692-4B01-9D65-641A547C16CE Q37166953-E6CF1A92-3098-4F6B-9F43-0FE1C1763F55 Q37620934-6A47CFE1-BEC8-4CDB-AF16-29CC1AA53779 Q37884450-BD6E791E-3972-461F-840F-D4E7C1868F5D Q38006725-C127DEAC-DFCA-48F6-9F2A-2FF7ADFE506F Q38046618-38C1CC48-72A3-4CE2-AFA4-A7442873DF2D Q38112350-FAADBEC5-B892-4B29-92F5-858C89DB3000 Q38170474-080A1DCB-85CD-4B41-9600-940EF8668284 Q38207841-02EB7599-8BAD-41BA-8049-E87ED4A45B93 Q38214892-41983AD2-37F4-41BF-8BB3-965082BE9304 Q38238027-178F551B-ABF1-4144-B5F4-8EFD1989881E Q39420474-1189AD7B-093B-40B0-A958-C99DD93B04E2 Q42124925-A800549A-ED97-4819-92C2-E4B206523221 Q42256221-568AE4F2-F028-444E-89ED-2CF219BEE4F5 Q42402000-586F4845-5F39-4F31-B238-2D3989178DF1 Q42554373-80FE63E7-294D-4EF9-B077-49BBA1665EAF Q42700805-B99F8E2F-5E04-41D1-BA6C-33F72F5D2E61 Q51146770-DCA9C7D4-CC3A-48FB-9474-488DF2206506 Q53665617-C4E1ABBA-E0DB-4028-AB7F-D4EBF11CE319 Q54517709-213E9D2A-BEC0-47A6-B003-99AF29AE3F30 Q54541508-7D6FBFF8-B18D-495C-96C6-D2F59D152631

P2860

Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.

http://www.wikidata.org/entity/Q35152116

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@ast

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@en

type

label

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@ast

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@en

prefLabel

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@ast

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@en

P1433

Q35152116-D8E8FB5A-163E-4CD6-B9FB-1FE182F1F45C

P1476

Q35152116-E05E3F05-008F-4FA5-A616-D1A8A15EBBF6

P2093

Q35152116-16C03100-2AE9-49FA-B693-AC6BBC8AAD2A

Q35152116-1DD70E2F-A284-4AF8-A3BC-D7186B67BFD6

Q35152116-3CEB721E-1273-4E19-94CA-B7C4356654BA

Q35152116-5EF03516-AF1A-445E-9F47-AD4F4ABAF62E

Q35152116-6A33CBE6-A3CC-42BE-A211-977C7A491651

Q35152116-709AD6A2-B733-4342-89B7-EEF11EF1480D

Q35152116-9012C0B8-97EA-424D-A988-86EE86489798

Q35152116-90CA4F18-9CD3-47B8-A3E7-2A294BBEDC4D

Q35152116-D1D687FA-9B6A-4F1C-A34C-32C907864909

Q35152116-E1B25C77-F093-4A0E-AF9C-2F80502C1127

P2860

Q35152116-05A86812-8E18-40FC-80CE-1D625B722384

Q35152116-0AB6DC93-F2E9-46C2-ACBC-59187117B576

Q35152116-11112D3A-2B20-4984-9EB3-BEB7B72D4F91

Q35152116-11A26C89-AC3A-4E43-903A-3B15A3EA774C

Q35152116-18A8C444-76AA-4C61-AB08-DBC335CA638E

Q35152116-22449374-04CA-4521-A586-62FC1DE6406A

Q35152116-2BD85873-9883-4DE3-87A5-07DE80BBDBE6

Q35152116-2DA3512F-3B0F-49F8-933E-298BDA3ECBFF

Q35152116-369D27DE-4677-4B8E-A759-99BC3AD8E08C

Q35152116-3D22A43E-5605-467D-AE8F-668A0AD38D8D

P304

Q35152116-98DC183B-BCA5-4101-9B4A-5BFEE7A91E4B

P31

Q35152116-8B12E41C-CE31-4EF5-8548-6CDDCFA4F8AB

P356

Q35152116-6E0082C5-56FB-4321-935E-71212A0292F5

P433

Q35152116-DE06C706-1EC4-482E-ACF4-E4067C2792A6

P478

Q35152116-077F14E4-2813-4059-8AB0-C66AC564AC54

P50

Q35152116-0317AB1A-A9F8-45A2-B512-4AD4037ADB6A

Q35152116-3AD16391-4D79-4520-B826-FA84B90B4D54

P577

Q35152116-98D58ED1-5D17-487A-B88D-34AF25D99528

P5875

Q35152116-6788C23D-02CB-4BF6-93BC-35E9C3DE712F

P698

Q35152116-1E4EBF79-DD8C-40A2-86F1-3FD86C999437

P921

Q35152116-1B8AD760-FEEB-4762-81A7-30089B5848E3

P932

Q35152116-A42329BD-F2D8-42EB-830B-3F91A3FF39F2

P356

P1433

Cardiovascular Research

P1476

Enhanced susceptibility to bio ...... 7(phox) NADPH oxidase subunit.

@en

P2093

Danny Guo

http://www.w3.org/2001/XMLSchema#string

Gavin Y Oudit

http://www.w3.org/2001/XMLSchema#string

George C Liu

http://www.w3.org/2001/XMLSchema#string

James W Scholey

http://www.w3.org/2001/XMLSchema#string

Jennifer Lo

http://www.w3.org/2001/XMLSchema#string

Jiu Chang Zhong

http://www.w3.org/2001/XMLSchema#string

Ratnadeep Basu

http://www.w3.org/2001/XMLSchema#string

Steven M Holland

http://www.w3.org/2001/XMLSchema#string

Wang Wang

http://www.w3.org/2001/XMLSchema#string

Zamaneh Kassiri

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress

NAD(P)H oxidase: role in cardiovascular biology and disease

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system

Effects of ACE2 inhibition in the post-myocardial infarction heart.

Oxidative stress and cardiovascular injury: Part II: animal and human studies.

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

P304

151-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVR036

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Josef M Penninger

Sreedhar Bodiga

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49802205

http://www.w3.org/2001/XMLSchema#string

P698

21285291

http://www.w3.org/2001/XMLSchema#string

P921

P932

3151662

http://www.w3.org/2001/XMLSchema#string